Attaboy Labs, Inc. has added approximately $800,000 in new annual recurring revenue (ARR) each month in recent months—a rare achievement for a company only 13 months into its operations. This consistent financial progress highlights the company’s rapid and sustained momentum, particularly for a direct-to-consumer brand in the competitive wellness sector.
The company's success is driven not by one-time sales but by strong customer retention through its subscription-based model. This reflects Attaboy's core belief that consumers are increasingly seeking a straightforward, trustworthy way to meet their wellness needs. Their focus is on delivering transparent, clinically dosed supplements that seamlessly integrate into daily routines, offering long-term value rather than short-term solutions.
Malar Group strengthens partnership
Malar Group, a strategic investment firm led by CEO Sayan Navaratnam, has deepened its relationship with Attaboy by expanding its investment and having Navaratnam join Attaboy’s board of directors. Malar initially supported Attaboy in April 2026 during the Friends & Family funding round, marking its entry as a strategic partner.
The decision to increase its stake and appoint Navaratnam to the board reflects Malar Group’s confidence in Attaboy’s proven performance over the past year. Instead of investing solely on the basis of potential, Malar has chosen to back a company that has consistently added revenue and retained customers. Navaratnam’s board seat underscores the firm’s commitment to actively supporting Attaboy’s growth beyond just financial backing.
Expanding product lines and new markets
Looking ahead, Attaboy is preparing to introduce new products to its lineup. Attagirl, a formulation tailored for women, is scheduled to launch in the second quarter of 2027. This expansion reflects the company’s goal to address diverse wellness needs while maintaining its commitment to clinically effective, transparent products.
The company is also planning to enter the Canadian market in the first half of 2027, as part of its broader strategy to scale globally. The Canadian expansion marks a key step toward international growth and reflects Attaboy's readiness to bring its product to a wider audience.
Attaboy’s flagship offering, Every Damn Day, is a once-daily supplement designed to support energy, focus, strength, recovery, and hydration. What sets it apart is its caffeine-free formula and absence of proprietary blends, ensuring full ingredient transparency. The product is manufactured in Utah and features third-party testing to confirm quality and compliance. Ingredients are carefully selected from globally sourced, high-quality materials.
Sayan Navaratnam, CEO of Malar Group, emphasized the company’s long-term belief in Attaboy during his remarks. We’re increasing our position after thirteen months of watching the business perform,' Navaratnam said. Taking a board seat is how we signal that we intend to help build this, not just fund it.'
Nick Lawhon, Founder and CEO of Attaboy Labs, Inc., echoed the sentiment, stating, 'Malar has been nothing short of a fantastic partner as we continue to grow, and has shown that through their increased investment in Attaboy.' The partnership between Malar and Attaboy is now more than financial—it is a strategic alliance with a shared vision for long-term growth and market expansion.
Malar Group, led by Navaratnam, is an investment firm focused on technology-driven companies and high-conviction consumer brands across various industries. It prioritizes long-term strategic partnerships, operator access, and global scaling support. Learn more about Malar Group at malargroup.com.
For more information about Attaboy Labs and its products, visit attaboylabs.com. For media inquiries, contact Nick Lawhon or Umar Qureshi through the provided channels.